Loteprednol etabonate ophthalmic suspension 0.5%
Alternative Names: Lotemax
Loteprednol etabonate ophthalmic suspension 0.5% is a corticosteroid eye drop used to treat allergic conjunctivitis and other inflammatory eye conditions. It works by reducing inflammation through immune suppression and has a lower risk of systemic side effects due to its ester-based formulation. Prolonged use may increase intraocular pressure (IOP), raising the risk of glaucoma.
Treatment Type: Prescription Medication
Treatment Class: Corticosteroids
Treatment Modality: Opthalmic/Otic
Review Summary
Loteprednol etabonate ophthalmic suspension 0.5% is effective as a second-line therapy for allergic conjunctivitis, offering rapid relief with a lower risk of steroid-associated complications compared to traditional corticosteroids. However, it is notably more expensive than alternative options.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
4.0
AI Summary of User Experiences
Not medical advice.
Loteprednol etabonate ophthalmic suspension 0.5% is effective as a second-line therapy for allergic conjunctivitis, offering rapid relief with a lower risk of steroid-associated complications compared to traditional corticosteroids. However, it is notably more expensive than alternative options.
Reviews
Filter by reviewer type Pro